SCHEMBL14924939

SCHEMBL14924939

Cc1cc(C)c(C(=O)NN)cc1Br

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.46
MAPT P10636 3/20 0.46
OGG1 O15527 1/20 0.42
ALDH1A1 P00352 6/20 0.42
GAA P10253 2/20 0.42
HPGD P15428 3/20 0.41
P2RX7 Q99572 1/20 0.40
LMNA P02545 1/20 0.39
GFER P55789 1/20 0.39
GPR27 Q9NS67 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C19 P33261 1/20 0.37
MTOR P42345 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27454181 0.78 NPC1 (0.38) ALDH1A1GAAHPGDGPR27NPC1
SCHEMBL20519345 0.78 NNMT (0.42) HPGDTDP1
SCHEMBL22468504 0.77 CYP1A2 (0.59) ALDH1A1HPGDLMNANPC1RAB9A
SCHEMBL789345 0.76 ALDH1A1 (0.55) KDM4EMAPTOGG1ALDH1A1GAA
SCHEMBL12909242 0.76 ALDH1A1 (0.55) KDM4EMAPTOGG1ALDH1A1GAA
SCHEMBL1878372 0.76 HPGD (0.62) KDM4EMAPTOGG1ALDH1A1GAA
SCHEMBL1459893 0.76 OGG1 (0.55) KDM4EMAPTOGG1ALDH1A1HPGD
SCHEMBL14924942 0.75 SMN1; SMN2 (0.46) KDM4EALDH1A1GAAHPGDGPR27
SCHEMBL9169776 0.75 CA1 (0.45) KDM4EMAPTOGG1ALDH1A1GAA
SCHEMBL155337 0.75 LCK (0.44) KDM4EALDH1A1GAAHPGDCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130116252-A1 Novel HSP90 Inhibitor NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2013-05-09 US disclosed
US-20130116431-A1 Novel HSP90 Inhibitor NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2013-05-09 US disclosed
US-20130116251-A1 Novel HSP90 Inhibitor NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2013-05-09 US disclosed
US-20130116253-A1 Novel HSP90 Inhibitor NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2013-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116252-A1 Novel HSP90 Inhibitor HSP90AB1, HSP90AB2P, HSP90B1 KDM4E 3055/4885MAPT 2935/4885OGG1 3778/4885
US-20130116253-A1 Novel HSP90 Inhibitor HSP90AB1, HSP90AB2P, HSP90B1 KDM4E 3055/4885MAPT 2935/4885OGG1 3778/4885
US-20130116251-A1 Novel HSP90 Inhibitor HSP90AB1, HSP90AB2P, HSP90B1 KDM4E 3055/4885MAPT 2935/4885OGG1 3778/4885
US-20130116431-A1 Novel HSP90 Inhibitor HSP90AB1, HSP90AB2P, HSP90B1 KDM4E 3055/4885MAPT 2935/4885OGG1 3778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.